Search results for:
ravulizumab
ravulizumab
- Non-formulary Ultomiris --> Restricted to outpatient hematologists using patient assistance program.
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Ultomiris |
SOLUTION, INTRAVENOUS |
300 mg/30 mL |
|
|
|
|
Last updated: Oct. 9, 2019
Ultomiris is restricted to hematologists in outpatient using patient assistance program (PAP). Using PAP results in a patient-specific supply being delivered to the facility. Ultomiris is considered non-formulary and should not be orderd from alternative means.
If outpatient use other than PAP is deemed medically necessary, refer prescriber to eculizumab (SOLIRIS).
Reviewed: 24 Sept 2019 (Ultomiris)